Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants.
BACKGROUND
The incidence of chronic lung disease (CLD) varies among groups defined by their early pattern of respiratory disease.


METHODS
The study examined data collected prospectively on 1204 of the 1506 infants born in 2002-2004 at 23-27 weeks gestation who survived to 36 weeks post-menstrual age. Based on their initial respiratory presentation and need for supplemental oxygen during the first 2 weeks, infants were classified as having early and persistent pulmonary dysfunction (EPPD), early recovery of pulmonary function followed by deterioration (PD) or consistently good pulmonary function characterised by low FiO(2) (Low FiO(2)).


RESULTS
CLD was diagnosed in 69% of infants with EPPD, 52% with PD, and 17% in the Low FiO(2) group. Birth weight z score <-1 conveyed information about CLD risk in all three groups and was the major risk factor for infants in the Low FiO(2) group (OR 27; 95% CI 7 to 95). Mechanical ventilation at 7 days was associated with increased risk in the PD (OR 4.2, 95% CI 2.5 to 6.9) and EPPD groups (OR 2.7, 95% CI 1.5 to 4.7), but not the Low FiO(2) group (OR 1.5, 95% CI 0.5 to 3.9).


CONCLUSIONS
The likelihood of a very preterm infant developing CLD and the profile of risk factors linked with CLD are related to the infant's pattern of respiratory disease during the first 2 postnatal weeks. Among infants with little exposure to oxygen during this period, fetal growth restriction, not mechanical ventilation, is the factor with the strongest association with CLD.
Laughon
Matthew
M
Division of Neonatal-Perinatal Medicine, School of Medicine, UNC Hospital, Chapel Hill, NC 27599-7596, USA. matt_laughon@med.unc.edu
Bose
Carl
C
Allred
Elizabeth N
EN
O'Shea
T Michael
TM
Ehrenkranz
Richard A
RA
Van Marter
Linda J
LJ
Leviton
Alan
A
D001724:Birth Weight; D002908:Chronic Disease; D004812:Epidemiologic Methods; D005260:Female; D005317:Fetal Growth Retardation / Q000453:epidemiology; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000453:epidemiology / Q000628:therapy*; D008171:Lung Diseases / Q000453:epidemiology / Q000209:etiology*; D008297:Male; D010920:Placenta / Q000382:microbiology / Q000473:pathology; D011247:Pregnancy; D011379:Prognosis; D012120:Respiration Disorders / Q000453:epidemiology / Q000628:therapy*; D012121:Respiration, Artificial / Q000009:adverse effects; D014481:United States / Q000453:epidemiology